CZ130胶囊治疗非酒精性脂肪性肝炎(湿热蕴结型)的随机、双盲、安慰剂对照、剂量探索、多中心Ⅱa期临床试验
[Translation] A randomized, double-blind, placebo-controlled, dose-finding, multicenter phase IIa clinical trial of CZ130 capsules in the treatment of nonalcoholic fatty hepatitis (damp-heat accumulation type)
主要目的:初步探索不同剂量下CZ130胶囊对非酒精性脂肪性肝炎(湿热蕴结型)患者肝脏炎症的治疗效果;
次要目的:(1)初步探索不同剂量下CZ130胶囊对非酒精性脂肪性肝炎(湿热蕴结型)患者的肝脏脂肪含量变化及肝脏纤维化改善情况;(2)初步探索不同剂量下CZ130胶囊治疗非酒精性脂肪性肝炎(湿热蕴结型)患者的安全性。
[Translation] Primary purpose: To preliminarily explore the therapeutic effect of CZ130 capsules at different doses on liver inflammation in patients with non-alcoholic fatty liver disease (damp-heat accumulation type);
Secondary purpose: (1) To preliminarily explore the effect of CZ130 capsules at different doses on the changes in liver fat content and improvement of liver fibrosis in patients with non-alcoholic fatty liver disease (damp-heat accumulation type); (2) To preliminarily explore the safety of CZ130 capsules at different doses in the treatment of patients with non-alcoholic fatty liver disease (damp-heat accumulation type).
岩黄连总碱胶囊在健康志愿者中多次给药耐受性和药代动力学探索的Ⅰ期临床研究
[Translation] Phase I clinical study on the tolerability and pharmacokinetics of Coptis chinensis total alkaloid capsules after repeated administration in healthy volunteers
1) 研究健康受试者多次口服岩黄连总碱胶囊的耐受性;
2) 探索健康受试者多次口服岩黄连总碱胶囊的人体药代动力学特征,为II期临床试验提供安全的剂量范围选择及给药方案依据提供参考。
[Translation] 1) To study the tolerance of healthy subjects to oral administration of Coptis chinensis Total Alkaloids Capsules for multiple times;
2) To explore the pharmacokinetic characteristics of Coptis chinensis Total Alkaloids Capsules for multiple times in healthy subjects, and to provide a reference for the selection of safe dose range and dosing regimen for Phase II clinical trials.
岩黄连总碱胶囊在健康志愿者中的单次给药耐受性和药代动力学探索的I期临床研究
[Translation] Phase I clinical study on single-dose tolerability and pharmacokinetics of Coptis chinensis total alkaloid capsule in healthy volunteers
主要目的: ? 研究健康受试者单次口服岩黄连总碱胶囊的耐受性 ? 探索健康受试者单次口服岩黄连总碱胶囊的人体药代动力学特征
[Translation] Main objectives: ? To study the tolerability of a single oral dose of Coptis chinensis total alkaloids capsules in healthy subjects ? To explore the pharmacokinetic characteristics of a single oral dose of Coptis chinensis total alkaloids capsules in healthy subjects
100 Clinical Results associated with Nanjing Hongjing Medical Technology Co., Ltd.
0 Patents (Medical) associated with Nanjing Hongjing Medical Technology Co., Ltd.
100 Deals associated with Nanjing Hongjing Medical Technology Co., Ltd.
100 Translational Medicine associated with Nanjing Hongjing Medical Technology Co., Ltd.